Please login to the form below

Not currently logged in
Email:
Password:

No-deal

This page shows the latest No-deal news and features for those working in and with pharma, biotech and healthcare.

COVID-19 delays Pfizer, Mylan’s generics merger and spin-out

COVID-19 delays Pfizer, Mylan’s generics merger and spin-out

Meanwhile, Mylan's meeting of shareholders to approve the deal is also being moved back from 27 April to 30 June. ... There are no changes to the terms of the deal, which will see Pfizer acquire Mylan, merge it with Upjohn and spin out the combined

Latest news

More from news
Approximately 3 fully matching, plus 133 partially matching documents found.

Latest Intelligence

  • Setting up for success in a post-Brexit, post-pandemic Britain Setting up for success in a post-Brexit, post-pandemic Britain

    mention Brexit deal negotiations going down to the wire, we have truly found ourselves in an unprecedented situation. ... Fortunately, we now have a deal in place, which has helped alleviate the uncertainty attached to a ‘no deal’ scenario.

  • Integrating competitive intelligence into business development, licensing and M&A strategy Integrating competitive intelligence into business development, licensing and M&A strategy

    In summary, all parties need competitive intelligence when seeking to find the right partner for a potential deal. ... By this it is safe to conclude that no BD&L or M&A deal should proceed without an abundance of CI integrated into the process.

  • The science of the deal The science of the deal

    The variables of these asymmetric R&D deals are so numerous and so diverse that there is no single, optimal deal structure, only a best deal structure for any given situation. ... So,. the question arises: what’s the best way to craft a deal?

  • Case study: Leading by example Case study: Leading by example

    how the sector should respond publicly to the threat of a ‘no deal’ scenario. ... The company was keen to reassure patients about the steps it has taken to keep a continuity of medical supplies in a ‘no deal’ scenario.

  • The mission matters The mission matters

    No leader or leadership team has the technical knowledge to fully understand, let alone micromanage, such a diverse and expert group. ... No other industry has the same sort of bargain with society, which has been beneficial to both sides.

More from intelligence
Approximately 0 fully matching, plus 29 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...
Don’t limit diversity to just representation in clinical trials
What is the power of diversity in the healthcare environment? Can it make clinical trials more inclusive?...
Oh no… not more training
Paul Hutchings, founder of fox&cat, discusses ways to help your team manage pressure in a more human, pressure-centric and engaging way...

Infographics